Microbiome Connect: 2024 - EUROPE | Kisaco Research | TBA, Amsterdam, Netherlands

A chance for senior executives to address shared challenges around innovative therapeutic development, build meaningful partnerships, and sharpen their R&D and commercial strategies. Bringing together the whole microbiome therapeutics ecosystem – from investors and large pharmaceutical companies through to the most pioneering biotechs, academic institutions and solution providers – it delivers the business-critical information you need to make strategic decisions for your organisation through in-depth case studies and expanded networking opportunities.

2023 Past Speakers

Gabriel Leventhal
CSO, PharmaBiome

Pedro Correa de Sampaio
CEO, Neobe Therapeutics

Romain Daillere
Head of Preclinical Research, Co-Founder, Everimmune

Jean-Luc Marsat
CEO, Everimmune

Aaron Cowley, Ph.D., MBA
Chief Scientific Officer, ReciBioPharm

Benjamin Hadida
Chief Executive Officer, Exeliom Biosciences

Sam Possemiers
Chief Executive Officer, MRM Health

Ryan Wilson
Head of Microbiome Services, SGS-Quay Pharma

Osnat Tirosh
Head of Microbiome Research and Innovation, Biomica

Juan Basterra
CEO, Mikrobiomik

Shahram Lavasani
CEO, ImmuneBiotech

Denise Kelly
Investment Advisor, Seventure Partners

Eric Van der Helm
VP Scientific Affairs, Bioinformatics & Automation, SNIPR Bio

Anna Chwalibog
CEO, Co-founder, Integral Solutions

Evelina Vågesjö, PhD MBA
CEO, Ilya Pharma

Nathalie Corvaia
CSO, MaaT Pharma

Chrysi Sergaki
Principal Investigator - Microbiome Group Leader, MHRA

Steve Emery
CSO, Chain Biotech

Sarah Lebeer
Professor, University of Antwerp

Ruben Vazquez Uribe
Co-principal Investigator, Novo Nordisk Foundation Center for Biosustainability

Adam Baker
Director of Sciences, Chr. Hansen

Harriet Schellekens
Lecturer, University College Cork

Pilar Manrique Ronquillo
Research Scientist, Microviable Tx

Rosanne Hertzberger
PI, Vrije Universiteit Amsterdam

Lothar Steidler
CTO, ActoBio Tx

Amine Zorgani
Director, R&D, S-Biomedic

Jonathan Swann
Professor, University of Southampton

Selin Bolca
Head of Development, MRM Health

Johan E.T. van Hylckama Vlieg
Chief Scientific Officer, Freya Biosciences

Caleb Bell
Venture Partner, CSB

Christophe Roca
Pilot Plant Manager, Sacco Systems

Stella Ackrell
VP, Pharmaceutical Development, Destiny Pharma